Airway Responsiveness to Indirect Challenges in COPD

REFERENCES

• Yan K, Salome CM, Woolcock AJ. Prevalence and nature of bronchial hyperresponsiveness in subjects with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 132:25–29.
   PubMed Web of Science ®Google Scholar
• Hargreave FE, Dolovich J, O’Byrne PM, Ramsdale EH, Daniel EE. The origin of airway hyperresponsiveness. J Allergy Clin Immunol 1986; 78:825–832.
   PubMed Web of Science ®Google Scholar
• Pride NB, Taylor RG, Lim TK, Joyce H, Watson A. Bronchial hyperresponsiveness as a risk factor for progressive airflow obstruction in smokers. Bull Eur Physiopathol Respir 1987; 23:369–375.
   PubMedGoogle Scholar
• Peat J, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70:171–179.
   PubMedGoogle Scholar
• Xu X, Rijcken B, Schouten JP, Weiss ST. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997; 350:1431–1434.
   PubMed Web of Science ®Google Scholar
• Jansen DF, Schouten JP, Vonk JM, Smoking and airway hyperresponsiveness especially in the presence of blood eosinophilia increase the risk to develop respiratory symptoms: a 25-year follow-up study in the general adult population. Am J Respir Crit Care Med 1999; 160:259–264.
   PubMed Web of Science ®Google Scholar
• Van Den Berge M, Kerstjens HAM, Postma DS. Provocation with adenosine 5#-monophosphate as a marker of inflammation in asthma, allergic rhinitis and chronic obstructive pulmonary disease. Clin Exp Allergy 2002; 32:824–830.
   PubMed Web of Science ®Google Scholar
• Collis MG, Hourani SM. Adenosine receptor subtypes. Trends Pharmacol Sci 1993; 14:3606.
   Google Scholar
• Marquardt DL, Walker LL. Inhibition of protein kinase A fails to alter mast cell adenosine responsiveness. Agents Actions 1994; 43:7–12.
   PubMedGoogle Scholar
• Ind PW, Barnes PJ, Durham SR, Kay AB. Propranolol induced bronchoconstriction in asthma: beta-receptor blockade and mediator release. Am Rev Respir Dis 1984; 129 Suppl:A10.
   Google Scholar
• Ind PW. Catecholamines. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, eds. Asthma. Philadelphia: Lippincott-Raven, 1997: 977–1008.
   Google Scholar
• Van Schoor J, Joos GF, Pauwels RA. Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur Respir J 2000; 16:514–533.
   PubMed Web of Science ®Google Scholar
• Carpentiere G, Castello F, Marino S. Effect of oral terfenadine on the bronchoconstrictor response to inhaled propranolol and histamine in asthmatics. Curr Ther Res 1991; 49:507–513.
   Web of Science ®Google Scholar
• Fujimura M, Abo M, Kamio Y, Effect of leukotriene and thromboxane antagonist on propranolol-induced bronchoconstriction. Am J Respir Crit Care Med 1999; 160:2100–2103.
   PubMed Web of Science ®Google Scholar
• Black JL, Salome, C., Yan, K, Shaw, J. The action of prazosin and propylene glycol on methoxamine-induced bronchoconstriction in asthmatic subjects. Br J Clin Pharmac 1984; 18:349–353.
   PubMed Web of Science ®Google Scholar
• Black J, Vincenc Kl, Salome C. Inhibition of methoxamine-induced bronchoconstriction by ipratropium bromide and disodium cromoglycate in asthmatic subjects. Br J Clin Pharmac 1985; 20:41–46.
   PubMed Web of Science ®Google Scholar
• Myou S, Fujimura M, Nishi K, Ohka T, Matsuda T. Aerosolized acetaldehyde induces histamine mediated bronchoconstriction in asthmatics. Am Rev Respir Dis 1993; 148:940–943.
   PubMed Web of Science ®Google Scholar
• Finnerty JP, Wilmot C, Holgate ST, Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen: evidence for the predominant role of histamine. Am Rev Respir Dis 1989; 140:593–597.
   PubMed Web of Science ®Google Scholar
• Smith CM, Anderson SD. Hyperosmolarity as the stimulus to asthma induced by hyperventilation? J Allergy Clin Immunol 1986; 77:729–736.
   PubMed Web of Science ®Google Scholar
• Smith CM, Anderson SD. A comparison between the airway response to isocapnic hyperventilation and hypertonic saline in subjects with asthma. Eur Respir J 1989; 2:36–43.
   PubMed Web of Science ®Google Scholar
• Anderson SD, Brannan J, Spring J, A new method for bronchialprovocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997; 156:758–765.
   PubMed Web of Science ®Google Scholar
• Porsbjerg C, Lund TK, Pedersen L, Backer V. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO. J Asthma 2009; 46(6):606–612.
   PubMed Web of Science ®Google Scholar
• Holzer K, Brukner P. Screening of athletes for exercise-induced bronchoconstriction. Clin J Sport Med 2004; 14(3):134–138.
   PubMed Web of Science ®Google Scholar
• Anderson SD, Daviskas E. The mechanism of exercise induced asthma. J Allergy Clin Immunol 2000; 106:453–459.
   PubMed Web of Science ®Google Scholar
• Eggleston PA, Kagey-Sobotka A, Lichtenstein LM. A comparison of the osmotic activation of basophils and human lung mast cells. Am Rev Respir Dis 1987; 135:1043–1048.
   PubMed Web of Science ®Google Scholar
• Duong M, Subbarao P, Adelroth E, Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. Chest 2008; 133:404–411.
   PubMed Web of Science ®Google Scholar
• Anderson SD, Kippelen P. Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes. J Allergy Clin Immunol 2008; 122:225–235.
   PubMed Web of Science ®Google Scholar
• Kanazawa H. Microvascular theory of exercise-induced bronchoconstriction in asthma: potential implications of vascular endothelial growth factor. Inflamm Allergy Drug Targets 2007; 6:133–137.
   PubMedGoogle Scholar
• Anderson SD, Brusasco V, Haahtela T, Criteria for diagnosis of asthma, EIB and AHR for athletes: lessons from the Olympic Games. Eur Respir Mon 2005; 33:48–66.
   Google Scholar
• Anderson SD, Argyros GJ, Magnussen H, Holzer K. Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med 2001; 35:344–347.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Altose MD, Bleecker ER, The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis 1992; 145:301–310.
   PubMed Web of Science ®Google Scholar
• Hargreave FE, Parameswaran K. Asthma, COPD and bronchitis are just components of airway disease. Eur Respir J 2006; 28:264–267.
   PubMed Web of Science ®Google Scholar
• Sears MR, Burrows B, Flannery EM, Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991; 325:1067–1071.
   PubMed Web of Science ®Google Scholar
• Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax 1984; 39:912–918.
   PubMed Web of Science ®Google Scholar
• Ramsdale EH, Roberts RS, Morris MM, Hargreave FE. Differences in responsiveness to hyperventilation and methacholine in asthma and chronic bronchitis. Thorax 1985; 40:422–426.
   PubMed Web of Science ®Google Scholar
• Godfrey S, Springer C, Noviski N, Ch Maayan, Avital A. Exercise but not methacholine differentiates asthma from chronic lung disease in children. Thorax 1991; 46:488–492.
   PubMed Web of Science ®Google Scholar
• Avital A, Springer C, Bar-Yishay E, Godfrey S. Adenosine, methacholine and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 1995; 50:511–516.
   PubMed Web of Science ®Google Scholar
• Woolcock AJ, Anderson SD, Peat JK, Characteristics of bronchial hyper-responsiveness in chronic obstructive pulmonary disease and in asthma. Am Rev Respir Dis 1991; 143:1438–1443.
   PubMed Web of Science ®Google Scholar
• Du toit JI, Woolcock AJ, Salome CM, Sundrum R, Black JL. Characteristics to bronchial hyperresponsiveness in smokers with chronic airflow limitation. Am Rev Respir Dis 1986; 134:498–501.
   PubMed Web of Science ®Google Scholar
• Sanchez-Toril F, Prieto L, Peris R, Perez JA, Millan M, Marin J. Differences in airway responsiveness to acetaldehyde and methacholine in asthma and chronic bronchitis. Eur Respir J 2000; 15:260–265.
   PubMed Web of Science ®Google Scholar
• Oosterhoff Y, De Jong JW, Jansen MAM, Koeter GH, Postma DS. Airway responsiveness to adenosine 5 monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am Rev Respir Dis 1993; 147:553–558.
   PubMed Web of Science ®Google Scholar
• Oosterhoff Y, Jansen MAM, Postma DS, Koeter GH. Airway responsiveness to adenosine 5-monophosphate in smokers and nonsmokers with atopic asthma. J Allergy Clin Immunol 1993; 92:773–776.
   PubMed Web of Science ®Google Scholar
• Piccillo G, Caponnetto P, Barton S, Changes in airway hyperesponsiveness following smoking cessation: Comparisons between Mch and AMP. Respiratory Medicine 2008; 102:256–265.
   PubMed Web of Science ®Google Scholar
• Polosa R, Rorke S, Holgate ST. Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Thorax 2002; 57;649–654.
   PubMed Web of Science ®Google Scholar
• Kraan J, Koeter GH, Van Der Mark TW, Sluiter HJ, De Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985; 76:628–636.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O’Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990; 142:832–836.
   PubMed Web of Science ®Google Scholar
• Weir DC, Burge PS. Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow limitation. Thorax 1993; 48:309–316.
   PubMed Web of Science ®Google Scholar
• Boothma-Burrell D, Delany SG, Flannery EM, Hancox RJ, Taylor DR. The efficacy of inhaled corticosteroids in the management of non-asthmatic chronic airflow obstruction. N Z Med J 1997; 110:370–373.
   PubMedGoogle Scholar
• Rutgers SR, Koeter GH, Van Der Mark TW, Postma DS. Short term treatment with budesonide does not improve hyperresponsiveness to adenosine 5-monophosphate in COPD. Am J Respir Crit Care Med 1998; 157:880–886.
   PubMed Web of Science ®Google Scholar
• Polosa R, Rajakulasingam K, Prosperini G, Budesonide attenuates bronchial reactivity to AMP to a greater extent than to methacholine in mild asthma. Thorax 1993; 48:415.
   Google Scholar
• Wilson AM, Lipworth BJ. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. Am J Med 2000; 108:269–275.
   PubMed Web of Science ®Google Scholar
• Ketchell RI, Jensen MW, Lumley P, Rapid effect of a single dose of inhaled fluticasone propionate on airway responsiveness to AMP in mild asthma. Am J Respir Crit Care Med 2001; 163:A420.
   PubMedGoogle Scholar
• Leuppi JD, Tandjung R, Anderson SD, Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept. Pulm Pharmacol Ther 2005; 18:83–88.
   PubMed Web of Science ®Google Scholar
• Saetta M, Di Stefano A, Maestrelli P, Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147:301.
   PubMed Web of Science ®Google Scholar
• Pizzichini E, Pizzichini MM, Gibson P, Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998; 158:1511–1517.
   PubMed Web of Science ®Google Scholar
• Pesci A, Rossi G, 1994. Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis. Am. J. Respir. Crit. Care Med 149(5): 1311–1316.
   PubMed Web of Science ®Google Scholar
• Hargreave FE, Leigh R. Induced sputum, eosinophilic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:S53–57.
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Capelli A, Lusuardi M, Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158:1277–1285.
   PubMed Web of Science ®Google Scholar
• Stanescu D, Sanna A, Veriter C, Airways obstruction, chronic expectoration, and rapid decline in FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51:267–271.
   PubMed Web of Science ®Google Scholar
• Leigh R, Pizzichini MM, Morris MM, Maltais F, Hargreave FE, Pizzichini E. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J 2006; 27: 964–971.
   PubMed Web of Science ®Google Scholar
• Green RH, Brightling CE, McKenna S, Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. Eur Respir J 2006; 27:1144–1151.
   PubMed Web of Science ®Google Scholar
• Wilson AM, Duong M, Pratt B, Anti-inflammatory effects of once daily low dose inhaled ciclesonide in mild to moderate asthmatics patients. Allergy 2006; 67:537–542.
   Google Scholar
• Van Den Berge M, Meijer RJ, Kerstjens HA, PC20 adenosine 5-monophosphate is more closely associated with airway inflammation in asthma than PC20 methacholine. Am J Respir Crit Care Med 2001;163:1546–1550.
   PubMed Web of Science ®Google Scholar
• Rutgers SR, Timens W, Tzanakis N, Airway inflammation and hyper-responsiveness to adenosine 5-monophosphage in chronic obstructive pulmonary disease. Clin Exp Allergy 2000; 30:657–662.
   PubMed Web of Science ®Google Scholar
• Finkelstein R, Ma HD, Ghezzo H, Whittaker K, Fraser RS, Cosio MG. Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness. Am J Respir Crit Care Med 1995;152:267–276.
   PubMed Web of Science ®Google Scholar